📇 Rhumatologue · ANTONY · (92) · Libéral
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
25 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
136 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR ANNE-MARIE SOULIER-LEBRUN
CABINET DE MEDECINE GENERALE 22 RUE PASTEUR, 92160 ANTONY
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2018
Climacteric : the journal of the International Menopause Society · 2020
Pain medicine (Malden, Mass.) · 2023
AbstractObjectiveTo evaluate the effectiveness of Tuina in relieving the pain, negative emotions, and disability of patients with knee osteoarthritis (KOA).DesignSingle-center, parallel, randomized controlled trial.SettingShanghai Guanghua Integrated Chinese and Western Medicine Hospital, Shanghai, China.SubjectsAdult patients with KOA who were able to speak Chinese and self-report symptoms were eligible.MethodsA total of 104 patients were randomly allocated to receive the 6-week treatment of Tuina (Tuina group) or celecoxib (celecoxib group). Data on pain, negative emotions, and disability were collected at baseline, at week 2, 4, and 6, and follow-up (1 month after the last treatment). The primary outcomes were the pressure pain thresholds. The secondary outcomes were: (1) numerical rating scale at rest and with movement; (2) Hamilton Anxiety Scale; (3) Hamilton Depression Scale; (4) Western Ontario and McMaster Universities Osteoarthritis Index; and (5) clinical effective rate. The adverse events of the trial were evaluated.ResultsIn total, 99 patients completed the follow-up. Generalized linear mixed models were constructed to analyse the between-group differences. Statistically significant differences were found in the interaction effects (P < .05). In evaluating the group effect, statistical differences were found at week 6 and follow-up (P < .05). Further, all variables showed a time effect (P < .05). A statistical difference in the clinical effective rate was found between the Tuina and celecoxib groups (P < .05).ConclusionsTuina produced superior effects for pain, negative emotions, and disability over time, as compared to celecoxib in patients with KOA.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Chinese medicine · 2025 · Journal Article
Bian Y, Li F, A X, Xiang Z, et al.
Scientific reports · 2025 · Journal Article
M C S, B K, A U, K C S
Biomacromolecules · 2024 · Journal Article
Kabir A, B M, A N, Selvaraj V, et al.
American journal of translational research · 2023 · Journal Article
A R, Mu R, Wu Q, Ga L, et al.
Journal of clinical medicine · 2021 · Journal Article
A G, Yano S, Sheik AM, Yu A, et al.
Osteoarthritis and cartilage open · 2021 · Journal Article
A D, A T, T J, O R, et al.
Climacteric : the journal of the International Menopause Society · 2020 · Journal Article
Luo Y, Ma Y, Qiao X, Zeng R, et al.
Open forum infectious diseases · 2020 · Journal Article
Laure B, Jacques F, Mathilde P, Anne-Marie R, et al.
Annals of agricultural and environmental medicine : AAEM · 2020 · Journal Article
Brice L, Jean-Dominique D, Laurent M, Philippe S, et al.
The Pan African medical journal · 2019 · Journal Article
N'goran K, Eric KK, Brahima D, Alihonou S, et al.
The open orthopaedics journal · 2015 · Journal Article
H N, A P S, S B, A U, et al.
JMIR research protocols · 2025 · Journal Article
M A, Ahmad A, A A, Raj LS, et al.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2016 · Journal Article
Nicolas C, Sylvain M, Come L, Jean F, et al.
Dentistry journal · 2023 · Journal Article
De Grado Gabriel F, Clément B, Florence F, Anne-Marie M, et al.
Pain medicine (Malden, Mass.) · 2023 · Randomized Controlled Trial
Xu H, Zhao C, Guo G, Li Y, et al.
Cureus · 2025 · Journal Article
Muraleedharan A, Chaubey S, A S, Yadav A
Revue de l'infirmiere · 2016 · English Abstract
A M
Clinical rheumatology · 2025 · Journal Article
A K, M EA, M H, H A, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2026 · Journal Article
Xin P, Li W, A X, Shen J, et al.
Cureus · 2024 · Case Reports
Ravichandran S, Kumar J, Chandrasekaran ND, Irfan S, et al.
Frontiers in pharmacology · 2023 · Journal Article
Ran L, Xu B, Han HH, Wang JY, et al.
Brain and behavior · 2022 · Journal Article
Kang BX, Ma J, Shen J, Xu H, et al.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2018 · Journal Article
Cao W, Qian G, Luo W, Liu X, et al.
Archives of osteoporosis · 2025 · Journal Article
N BV, A MS, A DR, H SG, et al.
Pediatric pulmonology · 2025 · Journal Article
Anne-Marie DP, Leah G, Nyathi NM, Stephanie GR, et al.
Pain medicine (Malden, Mass.) · 2023 · Randomized Controlled Trial
Xu H, Zhao C, Guo G, Li Y, et al.